Position in JAZZ
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$5,301
+$5,038 QoQ
Shares Held
22
+1000.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#61
of 69 holders
Holding Since
Jun 2022
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JAZZ Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026City State Bank holds $329,997 across 10 Biotechnology names. JAZZ ranks #7 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZVRA |
Zevra Therapeutics, Inc.
|
13,798 | $197,863 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
160 | $79,476 | |
| 3 | INCY |
Incyte Corp
|
147 | $16,663 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
200 | $11,444 | |
| 5 | HALO |
Halozyme Therapeutics, Inc.
|
110 | $8,609 | |
| 6 | DNLI |
Denali Therapeutics Inc.
|
250 | $6,430 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
This page
|
22 | $5,301 | |
| 8 | MRNA |
Moderna, Inc.
|
50 | $3,501 |
All Filings in JAZZ
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,301 | 22 | Shares | Sole | 2026-07-14 | |
| 2025-09-30 | $263 | 2 | Shares | Sole | 2025-10-16 | |
| 2025-06-30 | $212 | 2 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $248 | 2 | Shares | Sole | 2025-04-11 | |
| 2024-12-31 | $246 | 2 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $222 | 2 | Shares | Sole | 2024-10-10 | |
| 2024-06-30 | $213 | 2 | Shares | Sole | 2024-07-09 | |
| 2022-09-30 | $266 | 2 | Shares | Sole | 2022-10-24 | |
| 2022-06-30 | $312 | 2 | Shares | Sole | 2022-08-22 | |
| No filing history on record for this holder in this stock. | ||||||